These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9526946

  • 1. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets.
    Sheu JR, Kan YC, Hung WC, Ko WC, Yen MH.
    Thromb Res; 1997 Nov 01; 88(3):259-70. PubMed ID: 9526946
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavoviridis snake venom.
    Huang TF, Sheu JR, Teng CM.
    Thromb Haemost; 1991 Oct 01; 66(4):489-93. PubMed ID: 1665595
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms involved in the antiplatelet activity of magnesium in human platelets.
    Sheu JR, Hsiao G, Shen MY, Fong TH, Chen YW, Lin CH, Chou DS.
    Br J Haematol; 2002 Dec 01; 119(4):1033-41. PubMed ID: 12472585
    [Abstract] [Full Text] [Related]

  • 7. Morphine-potentiated agonist-induced platelet aggregation through alpha2-adrenoceptors in human platelets.
    Sheu JR, Yeh GC, Fang CL, Lin CH, Hsiao G.
    J Cardiovasc Pharmacol; 2002 Nov 01; 40(5):743-50. PubMed ID: 12409983
    [Abstract] [Full Text] [Related]

  • 8. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase.
    Kang WS, Chung KH, Chung JH, Lee JY, Park JB, Zhang YH, Yoo HS, Yun YP.
    J Cardiovasc Pharmacol; 2001 Dec 01; 38(6):875-84. PubMed ID: 11707691
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms involved in the antiplatelet activity of ketamine in human platelets.
    Chang Y, Chen TL, Wu GJ, Hsiao G, Shen MY, Lin KH, Chou DS, Lin CH, Sheu JR.
    J Biomed Sci; 2004 Dec 01; 11(6):764-72. PubMed ID: 15591773
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
    Sheu JR, Hsiao G, Shen MY, Wang Y, Lin KH, Lin CH, Chou DS.
    Exp Biol Med (Maywood); 2003 Dec 01; 228(11):1321-8. PubMed ID: 14681547
    [Abstract] [Full Text] [Related]

  • 11. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD, Seewaldt-Becker E, Himmelsbach F, Weisenberger H, Müller TH.
    J Cardiovasc Pharmacol; 1997 Aug 01; 30(2):261-72. PubMed ID: 9269956
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist.
    Moritani Y, Sato K, Shigenaga T, Hisamichi N, Ichihara M, Akamatsu S, Suzuki Ki, Nii T, Kaku S, Kawasaki T, Matsumoto Y, Inagaki O, Tomioka K, Yanagisawa I.
    Eur J Pharmacol; 2002 Mar 29; 439(1-3):43-52. PubMed ID: 11937091
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.